Solid Low-Grade In Situ Carcinoma of the Breast
- 1 February 2001
- journal article
- Published by Wolters Kluwer Health in The American Journal of Surgical Pathology
- Vol. 25 (2) , 237-244
- https://doi.org/10.1097/00000478-200102000-00012
Abstract
Low-grade solid in situ carcinomas of the breast are difficult to classify. The authors investigated 12 cases of in situ carcinomas with equivocal features and correlated their histologic attributes with those of the associated invasive carcinomas as well as with E-cadherin expression in both in situ and invasive disease. E-cadherin-positive in situ lesions were invariably associated with invasive carcinomas of the ductal type. In situ carcinomas that were E-cadherin negative were associated with invasive carcinomas of the lobular type in five of six cases. In all cases, the invasive carcinomas showed the same pattern of E-cadherin reactivity as the in situ lesions. Sharply defined cellular membranes, necrosis, and occasional microacini were seen in both E-cadherin-positive and negative in situ carcinomas, whereas intracytoplasmic lumina and a noncohesive appearance were seen only in E-cadherin-negative lesions.Keywords
This publication has 18 references indexed in Scilit:
- Chromosome alterations and E-cadherin gene mutations in human lobular breast cancerBritish Journal of Cancer, 1999
- Atypical lobular hyperplasia and lobular carcinoma in situ: surgical and molecular pathologyHistopathology, 1999
- Distinct cadherin profiles in special variant carcinomas and other tumors of the breastHuman Pathology, 1999
- Breast carcinoma developing in patients on hormone replacement therapy: a histological and immunohistological study.Journal of Clinical Pathology, 1998
- Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinomain situThe Journal of Pathology, 1997
- A Comparative Study of Pure Tubular and Tubulolobular Carcinoma of the BreastThe American Journal of Surgical Pathology, 1997
- E-cadherin quantititive immunocytochemical assays in breast carcinomasThe Journal of Pathology, 1997
- E-Cadherin (E-cad) expression in duct carcinoma in situ (DCIS) of the breastVirchows Archiv, 1997
- Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17: Five-year observations concerning lobular carcinoma in situCancer, 1996
- Epithelial‐cadherin Gene Is Not Mutated in Ductal Carcinomas of the BreastJapanese Journal of Cancer Research, 1995